Private Advisor Group, LLC Sorrento Therapeutics, Inc. Transaction History

Private Advisor Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$1.24 - $2.33 $3,946 - $7,416	-3,183 Reduced 21.66%	11,509 $23,000
Q1 2022 May 12, 2022	SELL	$2.0 - $4.9 $18,726 - $45,878	-9,363 Reduced 38.92%	14,692 $34,000
Q4 2021 Feb 10, 2022	SELL	$4.65 - $7.23 $59,264 - $92,146	-12,745 Reduced 34.63%	24,055 $112,000
Q3 2021 Oct 14, 2021	SELL	$7.41 - $10.99 $7,595 - $11,264	-1,025 Reduced 2.71%	36,800 $281,000
Q2 2021 Aug 12, 2021	BUY	$6.35 - $10.0 $61,391 - $96,680	9,668 Added 34.34%	37,825 $367,000
Q1 2021 Apr 22, 2021	BUY	$7.03 - $16.51 $197,943 - $464,872	28,157 New	28,157 $233,000
Q4 2020 Apr 01, 2021	SELL	$5.76 - $11.95 $60,088 - $124,662	-10,432 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$6.17 - $18.82 $44,510 - $135,767	7,214 Added 224.18%	10,432 $116,000
Q2 2020 Aug 17, 2020	BUY	$1.73 - $6.76 $5,567 - $21,753	3,218 New	3,218 $20,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.